List of Excipients in API nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline
Detailed excipient profiles for nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline
Excipient focus: ALGINIC ACID
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing ALGINIC ACID
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing ALGINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline | 0378-3422 |
| Central Texas Community Health Centers | nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline | 76413-115 |
| >Company | >Ingredient | >NDC |
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline | 54868-6203 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline | 54868-6203 |
| >Company | >Ingredient | >NDC |
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline | 0378-3422 |
| Central Texas Community Health Centers | nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline | 76413-115 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing CELLULOSE, MICROCRYSTALLINE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing D&C YELLOW NO. 10
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing FD&C BLUE NO. 1
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing FD&C BLUE NO. 2
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing FD&C RED NO. 40
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing FD&C YELLOW NO. 6
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing FERRIC OXIDE RED
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing FERRIC OXIDE YELLOW
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing FERROSOFERRIC OXIDE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing GELATIN
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline | 0378-3422 |
| Central Texas Community Health Centers | nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline | 76413-115 |
| >Company | >Ingredient | >NDC |
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline | 54868-6203 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline | 54868-6203 |
| >Company | >Ingredient | >NDC |
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline | 0378-3422 |
| Central Texas Community Health Centers | nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline | 76413-115 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing LACTOSE MONOHYDRATE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing MAGNESIUM STEARATE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing PROPYLENE GLYCOL
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing SHELLAC
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ALGINATE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing SODIUM ALGINATE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing SODIUM ALGINATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing SODIUM LAURYL SULFATE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants containing TITANIUM DIOXIDE
nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links